Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 41-50 of 2836 for cancer

Edit search filters
  1. A Study to Develop Early Detection Test to Reduce Racial Disparities in Endometrial Cancer (EC) Mortality

    Jacksonville, FL

  2. A Study to Analyze The Impact of Pharmacist Consultation in Patients Beginning Intravenous Cancer Treatment

    La Crosse, WI

  3. Study to Test the Safety and Tolerability of PF-07257876 in Participants with Selected Advanced Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer

    Scottsdale/Phoenix, AZ

  5. A Study to Evaluate Reiki Therapy as an Intervention in Hematology/Oncology Cancer Patients Hospitalized in an Inpatient Setting

    Rochester, MN

  6. A Study of TAS-120 in Patients With Metastatic Breast Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN, Jacksonville, FL

  7. A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression

    Rochester, MN

  8. A Safety and Efficacy Study of Intravenous (IV) Elezanumab Assessing Change in Neurologic Function in Adult Participants With Acute Ischemic Stroke (EAISE)

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  9. A Study to Evaluate Zanubrutinib to Treat Patients with B-cell Malignancies

    Rochester, MN

  10. Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

    Jacksonville, FL

.

Mayo Clinic Footer